Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals
Deal Bird & Bird advises Engrate on €2.5 Million Capital Raise

Jun 26 2025

Read More
News Bird & Bird secures multiple wins at the Women in Business Law Awards 2025

Jun 26 2025

Read More
Deal Bird & Bird advises CapMan Plc on majority acquisition of CAERUS Debt Investments AG

Jun 24 2025

Read More
News Bird & Bird wins Five Awards at the LMG Life Sciences Awards EMEA 2025

Jun 18 2025

Read More
Deal Bird & Bird advises Gulermak Renewables Ltd on the acquisition of a 42.4 MW UK solar project

Jun 18 2025

Read More
Deal Bird & Bird advises Hoivatilat Oyj on the purchase of a care facility portfolio

Jun 17 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare